| Dr Aalap Shah, MD | |
|
171 Ashley Ave, Charleston, SC 29425 | |
| (843) 792-1414 | |
| Not Available |
| Full Name | Dr Aalap Shah |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 10 Years |
| Location | 171 Ashley Ave, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356760078 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Musc Medical Center | Charleston, SC | Hospital |
| Tidelands Georgetown Memorial Hospital | Georgetown, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Associates Of The Medical University Of South Carol | 6305758574 | 1297 |
| Georgetown Memorial Hospital | 8224942123 | 69 |
News Archive
Authentidate Holding Corp., a worldwide provider of secure Health Information Exchange and workflow management services, has introduced an interface that allows Inscrybe® Healthcare to be easily integrated with one of the homecare industry's leading information systems, Definitive Homecare Solutions' CPR+(TM).
QLT Inc. announced that the parties have settled the litigation brought in 2001 by Massachusetts Eye and Ear Infirmary ("MEEI") against QLT and Novartis Ophthalmics, Inc., case # 01-10747, in the United States District Court for the District of Massachusetts (the "District Court").
New research by a team of scientists at The Hong Kong University of Science and Technology sheds light on the epitopic targets of SARS-CoV-2 by T cells in COVID-19 convalescents. The team's findings suggest that the epitopes targeted by T cells during infection may not be affected by the emergence of SARS-CoV-2 variants.
Mission Pharmacal Company announced today that it is developing a new drug delivery system utilizing technology developed by TriLogic Pharma. The delivery system will be based upon TriLogic's proprietary drug delivery platform TRI-726 and will be licensed to Mission Pharmacal for future drug development.
› Verified 3 days ago
| Entity Name | University Medical Associates Of The Medical University Of South Carol |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043241110 PECOS PAC ID: 6305758574 Enrollment ID: O20031105000291 |
News Archive
Authentidate Holding Corp., a worldwide provider of secure Health Information Exchange and workflow management services, has introduced an interface that allows Inscrybe® Healthcare to be easily integrated with one of the homecare industry's leading information systems, Definitive Homecare Solutions' CPR+(TM).
QLT Inc. announced that the parties have settled the litigation brought in 2001 by Massachusetts Eye and Ear Infirmary ("MEEI") against QLT and Novartis Ophthalmics, Inc., case # 01-10747, in the United States District Court for the District of Massachusetts (the "District Court").
New research by a team of scientists at The Hong Kong University of Science and Technology sheds light on the epitopic targets of SARS-CoV-2 by T cells in COVID-19 convalescents. The team's findings suggest that the epitopes targeted by T cells during infection may not be affected by the emergence of SARS-CoV-2 variants.
Mission Pharmacal Company announced today that it is developing a new drug delivery system utilizing technology developed by TriLogic Pharma. The delivery system will be based upon TriLogic's proprietary drug delivery platform TRI-726 and will be licensed to Mission Pharmacal for future drug development.
› Verified 3 days ago
| Entity Name | Georgetown Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982604021 PECOS PAC ID: 8224942123 Enrollment ID: O20031114000600 |
News Archive
Authentidate Holding Corp., a worldwide provider of secure Health Information Exchange and workflow management services, has introduced an interface that allows Inscrybe® Healthcare to be easily integrated with one of the homecare industry's leading information systems, Definitive Homecare Solutions' CPR+(TM).
QLT Inc. announced that the parties have settled the litigation brought in 2001 by Massachusetts Eye and Ear Infirmary ("MEEI") against QLT and Novartis Ophthalmics, Inc., case # 01-10747, in the United States District Court for the District of Massachusetts (the "District Court").
New research by a team of scientists at The Hong Kong University of Science and Technology sheds light on the epitopic targets of SARS-CoV-2 by T cells in COVID-19 convalescents. The team's findings suggest that the epitopes targeted by T cells during infection may not be affected by the emergence of SARS-CoV-2 variants.
Mission Pharmacal Company announced today that it is developing a new drug delivery system utilizing technology developed by TriLogic Pharma. The delivery system will be based upon TriLogic's proprietary drug delivery platform TRI-726 and will be licensed to Mission Pharmacal for future drug development.
› Verified 3 days ago
| Entity Name | Waccamaw Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972503910 PECOS PAC ID: 9133036932 Enrollment ID: O20031126000386 |
News Archive
Authentidate Holding Corp., a worldwide provider of secure Health Information Exchange and workflow management services, has introduced an interface that allows Inscrybe® Healthcare to be easily integrated with one of the homecare industry's leading information systems, Definitive Homecare Solutions' CPR+(TM).
QLT Inc. announced that the parties have settled the litigation brought in 2001 by Massachusetts Eye and Ear Infirmary ("MEEI") against QLT and Novartis Ophthalmics, Inc., case # 01-10747, in the United States District Court for the District of Massachusetts (the "District Court").
New research by a team of scientists at The Hong Kong University of Science and Technology sheds light on the epitopic targets of SARS-CoV-2 by T cells in COVID-19 convalescents. The team's findings suggest that the epitopes targeted by T cells during infection may not be affected by the emergence of SARS-CoV-2 variants.
Mission Pharmacal Company announced today that it is developing a new drug delivery system utilizing technology developed by TriLogic Pharma. The delivery system will be based upon TriLogic's proprietary drug delivery platform TRI-726 and will be licensed to Mission Pharmacal for future drug development.
› Verified 3 days ago
| Entity Name | Carolina Family Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184655722 PECOS PAC ID: 4587557731 Enrollment ID: O20040203000627 |
News Archive
Authentidate Holding Corp., a worldwide provider of secure Health Information Exchange and workflow management services, has introduced an interface that allows Inscrybe® Healthcare to be easily integrated with one of the homecare industry's leading information systems, Definitive Homecare Solutions' CPR+(TM).
QLT Inc. announced that the parties have settled the litigation brought in 2001 by Massachusetts Eye and Ear Infirmary ("MEEI") against QLT and Novartis Ophthalmics, Inc., case # 01-10747, in the United States District Court for the District of Massachusetts (the "District Court").
New research by a team of scientists at The Hong Kong University of Science and Technology sheds light on the epitopic targets of SARS-CoV-2 by T cells in COVID-19 convalescents. The team's findings suggest that the epitopes targeted by T cells during infection may not be affected by the emergence of SARS-CoV-2 variants.
Mission Pharmacal Company announced today that it is developing a new drug delivery system utilizing technology developed by TriLogic Pharma. The delivery system will be based upon TriLogic's proprietary drug delivery platform TRI-726 and will be licensed to Mission Pharmacal for future drug development.
› Verified 3 days ago
| Entity Name | Musc Community Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841878006 PECOS PAC ID: 6507260668 Enrollment ID: O20210811002388 |
News Archive
Authentidate Holding Corp., a worldwide provider of secure Health Information Exchange and workflow management services, has introduced an interface that allows Inscrybe® Healthcare to be easily integrated with one of the homecare industry's leading information systems, Definitive Homecare Solutions' CPR+(TM).
QLT Inc. announced that the parties have settled the litigation brought in 2001 by Massachusetts Eye and Ear Infirmary ("MEEI") against QLT and Novartis Ophthalmics, Inc., case # 01-10747, in the United States District Court for the District of Massachusetts (the "District Court").
New research by a team of scientists at The Hong Kong University of Science and Technology sheds light on the epitopic targets of SARS-CoV-2 by T cells in COVID-19 convalescents. The team's findings suggest that the epitopes targeted by T cells during infection may not be affected by the emergence of SARS-CoV-2 variants.
Mission Pharmacal Company announced today that it is developing a new drug delivery system utilizing technology developed by TriLogic Pharma. The delivery system will be based upon TriLogic's proprietary drug delivery platform TRI-726 and will be licensed to Mission Pharmacal for future drug development.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aalap Shah, MD Po Box 751461, Charlotte, NC 28275-1461 Ph: (843) 792-6200 | Dr Aalap Shah, MD 171 Ashley Ave, Charleston, SC 29425 Ph: (843) 792-1414 |
News Archive
Authentidate Holding Corp., a worldwide provider of secure Health Information Exchange and workflow management services, has introduced an interface that allows Inscrybe® Healthcare to be easily integrated with one of the homecare industry's leading information systems, Definitive Homecare Solutions' CPR+(TM).
QLT Inc. announced that the parties have settled the litigation brought in 2001 by Massachusetts Eye and Ear Infirmary ("MEEI") against QLT and Novartis Ophthalmics, Inc., case # 01-10747, in the United States District Court for the District of Massachusetts (the "District Court").
New research by a team of scientists at The Hong Kong University of Science and Technology sheds light on the epitopic targets of SARS-CoV-2 by T cells in COVID-19 convalescents. The team's findings suggest that the epitopes targeted by T cells during infection may not be affected by the emergence of SARS-CoV-2 variants.
Mission Pharmacal Company announced today that it is developing a new drug delivery system utilizing technology developed by TriLogic Pharma. The delivery system will be based upon TriLogic's proprietary drug delivery platform TRI-726 and will be licensed to Mission Pharmacal for future drug development.
› Verified 3 days ago
Jordan James Mccarthy, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Ave # Msc300, Charleston, SC 29425 Phone: 843-876-8023 | |
Dr. Terry Kowalenko, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Steven H Saef, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Elizabeth Barton Winton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. Gary L. Rose, DNP, FNP, ENP, APRN Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1755 Ashley Hall Rd Apt E2, Charleston, SC 29407 Phone: 843-693-8385 | |
Dr. Kelli Marie Young, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2095 Henry Tecklenburg Dr, Charleston, SC 29414 Phone: 843-402-1037 Fax: 843-402-1295 | |
Patrick Gene Shen, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9330 Medical Center Plaza Dr, Charleston, SC 29406 Phone: 843-797-7000 |